JPH08504167A - スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン - Google Patents

スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン

Info

Publication number
JPH08504167A
JPH08504167A JP5514800A JP51480092A JPH08504167A JP H08504167 A JPH08504167 A JP H08504167A JP 5514800 A JP5514800 A JP 5514800A JP 51480092 A JP51480092 A JP 51480092A JP H08504167 A JPH08504167 A JP H08504167A
Authority
JP
Japan
Prior art keywords
epidermis
immunoglobulin
directed
immunoglobulins
elisa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5514800A
Other languages
English (en)
Japanese (ja)
Inventor
ダブリュ． フィッシャー，ジェラルド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Government of the United States of America
Original Assignee
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government of the United States of America filed Critical Government of the United States of America
Publication of JPH08504167A publication Critical patent/JPH08504167A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP5514800A 1992-02-25 1992-11-09 スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン Pending JPH08504167A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80431792A 1992-02-25 1992-02-25
US804,317 1992-02-25
PCT/US1992/009830 WO1993017044A1 (fr) 1992-02-25 1992-11-09 Immunoglobuline humaine dirigee pour la prevention et le traitement de staphylococcies

Publications (1)

Publication Number Publication Date
JPH08504167A true JPH08504167A (ja) 1996-05-07

Family

ID=25188685

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5514800A Pending JPH08504167A (ja) 1992-02-25 1992-11-09 スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン

Country Status (5)

Country Link
EP (1) EP0628056A4 (fr)
JP (1) JPH08504167A (fr)
AU (1) AU673508B2 (fr)
CA (1) CA2117480A1 (fr)
WO (1) WO1993017044A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132421C (fr) * 1992-03-19 2010-11-23 Gerald W. Fischer Anticorps opsoniques largement reactifs qui reagissent avec les antigenes des staphylocoques communs
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
JPH0840932A (ja) 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
EP2230249A3 (fr) 2003-02-06 2010-12-22 ChronTech Pharma AB Antigène/anticorps ou ligand/récepteur glycosyles avec un échangeur de spécificité
US20090214584A1 (en) * 2005-05-31 2009-08-27 Biostapro Ab Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis
EA016268B1 (ru) * 2009-05-12 2012-03-30 Государственное Учреждение ''Республиканский Научно-Практический Центр Трансфузиологии И Медицинских Биотехнологий'' Способ получения антистафилококковой плазмы крови
FR2989589A1 (fr) * 2012-04-20 2013-10-25 Univ Paris Curie Prevention et traitement des infections non virales chez des individus traites par des immunosuppresseurs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499035A (en) * 1975-04-10 1978-01-25 Ts Nii Gematologii I Perelivan Antistaphylococcus human immune globulin and method of preparing same
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus

Also Published As

Publication number Publication date
AU673508B2 (en) 1996-11-14
EP0628056A1 (fr) 1994-12-14
WO1993017044A1 (fr) 1993-09-02
EP0628056A4 (fr) 1997-03-05
CA2117480A1 (fr) 1993-09-02
AU3271893A (en) 1993-09-13

Similar Documents

Publication Publication Date Title
US6632432B1 (en) Directed human immune globulin for the prevention and treatment of staphylococcal infections
Wells et al. Clostridia: sporeforming anaerobic bacilli
US9981028B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
AU6857194A (en) Novel attenuated pseudomonas aeruginosa strains
JPH08504167A (ja) スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン
EP0635132A1 (fr) Anticorps opsoniques fortement reactifs, reagissant aux antigenes courants des staphylocoques
Greenberg et al. Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model
JP2000509961A (ja) 共通のブドウ球菌抗原と広範に反応するオプソニン作用性抗体
AU2012244060B2 (en) Polypeptides from staphylococcus aureus and methods of use
CA1339933C (fr) Utilisation de produit laitier hyperimmun pour traiter les troubles gastro-intestinaux
AU2015258239B2 (en) Polypeptides from staphylococcus aureus and methods of use
Rozalska et al. Role of antibodies against fibronectin-, collagen-binding proteins and alphatoxin in experimental Staphylococcus aureus peritonitis and septicaemia in neutropenic mice
Yeryomina et al. Clostridia: spore-forming anaerobic bacilli
HK1186126A (en) Polypeptides from staphylococcus aureus and methods of use